Supplement analysis backed by scientific evidence · PT

← All supplements
Limited evidenceBrain & cognition

Lecithin (Phosphatidylcholine)

A Cochrane review settled the memory question decades ago: lecithin does not help dementia or age-related memory loss. It is a legitimate dietary source of choline, but the same phosphatidylcholine is converted by gut bacteria into TMAO, a metabolite associated with cardiovascular events — a reason for restraint at high doses.

What the science says

  • Dementia and memory Limited evidence

    A Cochrane systematic review of 12 randomized trials found no evidence of benefit from lecithin in Alzheimer's disease, Parkinson's dementia, or age-associated memory impairment. Several trials used very large doses (up to 20-25 g/day) for months. Only one small trial in people with subjective memory complaints suggested any effect, which reviewers considered unreliable. The "lecithin for memory" premise, based on raising acetylcholine synthesis, does not survive testing.

  • Dietary choline source Moderate evidence

    Lecithin is a genuine source of choline, an essential nutrient with an Adequate Intake of 550 mg/day for men and 425 mg/day for women, and national surveys show most adults fall short. However, ordinary soy lecithin is only about 3-4% phosphatidylcholine-bound choline by weight, so a typical 1,200 mg softgel contributes very little; eggs and liver are dramatically more efficient sources.

  • TMAO and cardiovascular risk Moderate evidence

    In a landmark study, a dietary phosphatidylcholine challenge produced gut-microbe-derived trimethylamine N-oxide, and among 4,007 patients undergoing cardiac evaluation, those in the highest fasting TMAO quartile had roughly 2.5 times the risk of major adverse cardiovascular events over 3 years compared with the lowest. Causality in humans is unproven, but this is a real reason not to take gram-scale phosphatidylcholine casually, particularly with existing cardiovascular or kidney disease.

  • Cholesterol lowering Limited evidence

    Small short-term trials of high-dose polyenylphosphatidylcholine report LDL reductions of roughly 5-10%, but the studies are small, brief, frequently industry-funded, and not replicated in large independent trials. Lecithin should not be relied on for lipid management.

Dosage & safety

Studied doseConsumer products supply 1,200-2,400 mg/day of lecithin (granules or softgels). Dementia trials used far more, up to 20-25 g/day, without benefit. If choline is the actual goal, target the Adequate Intake of 425-550 mg/day, preferably from food. The commonly circulated lactation regimen for recurrent plugged milk ducts — 1,200 mg three to four times daily — is based on clinical anecdote, with no randomized trial behind it.
SafetyGenerally safe; the usual complaints are GI upset, diarrhea, nausea and a fishy body odor from trimethylamine, which is more pronounced in people with impaired flavin monooxygenase 3 activity. Soy-derived lecithin is a concern in soy allergy, though most refined lecithin contains negligible soy protein; sunflower lecithin is a soy-free alternative. The TMAO pathway argues for caution with gram-scale doses in chronic kidney disease and established cardiovascular disease. No meaningful drug interactions are documented. Not a banned substance in sport.

Scientific references

Where to buy

NOW Foods, Sunflower Lecithin, 200 Softgels (1.2 g per Softgel)

View on iHerb

Referral link — this site may earn a commission on purchases.

Related in Brain & cognition